Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,156.00
Bid: 12,124.00
Ask: 12,128.00
Change: -14.00 (-0.12%)
Spread: 4.00 (0.033%)
Open: 12,114.00
High: 12,258.00
Low: 12,114.00
Prev. Close: 12,170.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

FOREX-Dollar hits 4-month high as worries over European lockdowns, U.S. taxes sap risk appetite

Wed, 24th Mar 2021 09:21

* Graphic: World FX rates https://tmsnrt.rs/2RBWI5E

By Ritvik Carvalho

LONDON, March 24 (Reuters) - The dollar hit a four-month
high on Wednesday as concerns over a third COVID-19 wave in
Europe, potential U.S. tax hikes and escalating tensions between
the West and China sapped risk appetite.

The dollar index rose to a four-month top of 92.608
in early London trade, its highest since Nov. 23.

The gauge "looks determined to test the top end of a new,
higher 91-93 range we think will form in coming weeks," Westpac
strategists wrote in a client note, adding that extended
lockdowns in Europe have sapped confidence in an economic
rebound.

"Meanwhile, the U.S. will have an impressive rebound in
coming months amid a strong vaccine roll-out, stimulus payments
and economic reopenings," they said.

The index that measures the greenback's strength against a
basket of peer currencies is up nearly 3% year-to-date,
confounding widely held expectations among analysts for a
decline.

Strategists at BCA Research said they believe the U.S.
dollar is experiencing a "countertrend rally within a bear
market."

"Over the near-term, the dollar benefits from two supports.
First, the U.S. growth will outperform thanks to generous fiscal
policy and the country’s lead in vaccinations. Second, the
NASDAQ and other highflying global equities have been correcting
since February, creating some risk-off undertones that help the
countercyclical greenback."

"However, real interest rate differentials will ultimately
determine the currency’s cyclical outlook. The Fed’s commitment
to maintaining an accommodative policy will cap upside to US
real rates at the short-end of the curve. This will prevent a
sharp appreciation in the dollar.

The euro hit a four-month low of $1.1812 after
Germany extended a lockdown and urged its citizens to stay at
home during the Easter holiday.

Worries over the pace of the pandemic recovery were
heightened after a U.S. health agency said the AstraZeneca Plc
vaccine may have included outdated information in its
data.

The flight to safety received an additional nudge when
Treasury Secretary Janet Yellen told lawmakers that future tax
hikes will be needed to pay for infrastructure projects and
other public investments.

Yellen was testifying to the House Financial Services
Committee along with Federal Reserve Chair Jerome Powell, who
reiterated that an expected near-term spike in inflation will be
transitory.

That helped tame U.S. Treasury yields, with the benchmark
sinking below 1.6% on Wednesday for the first time
in a week, as it continued its retreat from a more than one-year
high of 1.7540% touched last week.

Both Yellen and Powell are also scheduled to testify to the
Senate Banking Panel on Wednesday.

Human rights sanctions on China imposed by the United
States, Europe and Britain, which prompted retaliatory sanctions
from Beijing, are adding to market concerns.

The safe-haven yen, which gained in Asian trade,
weakened 0.1% by the start of trading in London. Australia's
dollar - considered a liquid proxy for risk - weakened
further on Wednesday.

The Aussie slipped to as low as $0.7582, a level not seen
since Feb. 5.

The British pound weakened as far as $1.3675, also the
lowest since early February.

In cryptocurrencies, bitcoin gained 4% to
$56,500, off a record high of $61,781.83.

Seasonal factors are likely exacerbating currency moves, as
some investors lock in profits ahead of the quarter-end and the
holidays of Easter and Passover, according to Masafumi Yamamoto,
chief currency strategist at Mizuho Securities.

"The main scenario for the market, that the global economy
is recovering from the pandemic shock, is intact," he said.

"We may see more of a correction into the start of April,
but after that I expect a restarting of a risk-on trade," with
commodity currencies of advanced economies benefitting most, he
said.

(Reporting by Ritvik Carvalho; additional reporting by Kevin
Buckland in Tokyo)

More News
2 May 2024 10:04

AstraZeneca notes positive trial results for Calquence treatment

(Alliance News) - AstraZeneca PLC on Thursday said it observed positive high-level results in the Echo phase 3 trial of its Calquence treatment for previously untreated adult patients with mantle cell lymphoma.

Read more
2 May 2024 07:45

AstraZeneca reports positive results from blood cancer drug trial

(Sharecast News) - AstraZeneca has reported positive results from the use of its Calquence drug in a clinical trial to treat a rare type of blood cancer.

Read more
29 Apr 2024 22:52

J&J, Bristol Myers lose challenges to US drug price negotiation program

April 29 (Reuters) - A U.S. judge on Monday rejected a challenge by Bristol Myers Squibb and Johnson & Johnson to a law requiring them to negotiate the prices of their blockbuster blood clot prevention drugs with the U.S government's Medicare health insurance program or pay heavy penalties.

Read more
29 Apr 2024 10:02

LONDON BROKER RATINGS: Deutsche Bank likes Frasers; Barclays cuts JD

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning and Friday:

Read more
29 Apr 2024 09:13

AstraZeneca makes progress with Truqap and Enhertu cancer treatments

(Alliance News) - AstraZeneca PLC on Monday said its Truqap drug has been recommended for approval in the EU to treat a form of breast cancer, while also noting trial results for its Enhertu offering.

Read more
29 Apr 2024 07:50

LONDON BRIEFING: Hipgnosis Songs Fund backs new Blackstone bid

(Alliance News) - London's FTSE 100 is called to open higher on Monday, with heady gains for US tech stocks on Friday brightening the mood in Europe and Asia at the start of the new week.

Read more
29 Apr 2024 07:24

AstraZeneca makes progress with two breast cancer treatments

(Sharecast News) - AstraZeneca issued favourable updates on two of its breast cancer treatments on Monday - 'Truqap', or capivasertib, and 'Enhertu', or trastuzumab deruxtecan - following encouraging results from respective phase three trials.

Read more
26 Apr 2024 09:33

LONDON BROKER RATINGS: Peel Hunt cuts ConvaTec to 'reduce'

(Alliance News) - The following London-listed shares received analyst recommendations Friday morning:

Read more
25 Apr 2024 16:57

LONDON MARKET CLOSE: FTSE 100 shakes off red-hot US inflation gauge

(Alliance News) - London's FTSE 100 outperformed on Thursday, enjoying a solid rise on largely well-received corporate earnings and a share price jump for miner Anglo American after it received a takeover bid from peer BHP.

Read more
25 Apr 2024 15:14

London close: Stocks finish mixed as US GDP growth slows

(Sharecast News) - London's stock markets finished with a mixed performance on Thursday, as investors digested a slower-than-expected GDP growth reading from the United States, while a slew of well-received earnings underpinned the top-flight index.

Read more
25 Apr 2024 11:50

LONDON MARKET MIDDAY: FTSE 100 hits high on offer for Anglo American

(Alliance News) - The FTSE 100 was outperforming European markets at midday on Thursday, with the index boosted to a record high thanks to takeover talks.

Read more
25 Apr 2024 10:33

AstraZeneca leaps after smashing first-quarter forecasts

Q1 revenue up 19% to $12.68 bln

*

Read more
25 Apr 2024 09:18

TOP NEWS: AstraZeneca upbeat as cancer drugs underpin sales growth

(Alliance News) - AstraZeneca PLC on Thursday hailed the potential of its drugs pipeline as it delivered impressive growth in sales and profit in the first quarter.

Read more
25 Apr 2024 09:12

LONDON MARKET OPEN: Anglo American jumps on takeover bid from BHP

(Alliance News) - Stock prices in London opened mixed on Thursday, as investors cautiously eye data on the health of the US economy.

Read more
25 Apr 2024 08:38

AstraZeneca blows past analysts' estimates for Q1

(Sharecast News) - AstraZeneca posted better-than-expected revenues and profit for the first quarter of 2024 with both the company and analysts highlighting its drug pipeline.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.